1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6562D1E9150DA16210025886A0041DC7B
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-optimizing-competitive-intelligence-function-staffing-activities-budgeting?opendocument
18
19opendocument
203.223.3.251
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Competitive and Business Intelligence Resource/ Budget

Optimizing the Competitive Intelligence Function: Staffing, Activities, and Budgeting

ID: 5725


Features:

7 Info Graphics

12 Data Graphics

140+ Metrics

18 Narratives


Pages/Slides: 25


Published: 2022


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Optimizing the Competitive Intelligence Function: Staffing, Activities, and Budgeting”

STUDY OVERVIEW

An effective Competitive Intelligence function is integral to meet the ever-growing challenges in the pharmaceutical industry. However, Competitive Intelligence leaders often face a balancing act between developing competent capabilities and managing limited resources.

Best Practices, LLC undertook this benchmarking research to identify how leading pharmaceutical and biotechnology companies are improving the efficiency and effectiveness of their Competitive Intelligence function. In particular, this study delivers benchmarks and insights around staffing, activities, and budgeting of the Competitive Intelligence function.

KEY TOPICS

  • Competitive Intelligence Group Composition
  • Critical Competitive Intelligence Activities
  • Competitive Intelligence Activities Ranking
  • Competitive Intelligence Budget

KEY METRICS
  • Total number of full-time employees in the Competitive Intelligence function
  • Group composition of Competitive Intelligence function - Large companies vs. Small-mid sized companies
  • Activities conducted by the Competitive Intelligence function - Large companies and small-mid sized companies
  • Ranking importance vs. conduct of Competitive Intelligence activities - Large companies and small-mid sized companies
  • Ranking of Competitive Intelligence activities in order of importance for optimal performance of the function
  • Budget coordination for Competitive Intelligence activities

SAMPLE KEY FINDING
  • Competitive Intelligence Activities: Competitor product/portfolio profiling and competitor clinical trial tracking are the two top activities for both large and small–mid companies.

METHODOLOGY

Best Practices, LLC engaged 38 Competitive Intelligence leaders from 31 biopharmaceutical companies through a benchmarking survey instrument and focus group interviews. Directors / Heads were the major contributors to this study, followed by Managers.

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biopharmaceutical; Biotech; Manufacturing; Medical Device; Chemical; Consumer Products; Clinical Research; Laboratories; Consulting


Companies Profiled:
Abbott; Alkermes; Alnylam Pharmaceuticals; Amgen; Astellas; AstraZeneca; BioCryst Pharmaceuticals; Biogen; Bioventus; Cerevel Therapeutics; Clovis Oncology; CSL Behring; Daiichi Sankyo; Genentech; Ipsen; Ironwood; Novartis; Novo Nordisk; Orion Pharmaceuticals; Pfizer; Roche; Sanofi; SCIEX; Servier; Shire; Sunovion; Takeda Pharmaceuticals; Tesaro; Teva Pharmaceutical Industries Ltd; UCB Pharma; Uintah Consulting LLC

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.